The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Browse by »
Pneumonitis (ILD), subacute, moderate
No description available.
Last update :
No medias available.
Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.
Annals of hematology 1993 Oct;67;201-2 1993 Oct
Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma.
Internal medicine (Tokyo, Japan) 1997 May;36;360-4 1997 May
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993 May 04;13;267-74 1993 May 04
Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
British journal of cancer 1998 Jun;77;2286-90 1998 Jun